Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-10
1997-05-13
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514320, 514325, 514326, 546189, 546193, 546196, 546203, 546208, A61K 31445, C07D40106
Patent
active
056293240
ABSTRACT:
Compounds of the invention have the following structure: ##STR1## for example ##STR2## These compounds inhibit thrombin and associated thrombosis.
REFERENCES:
patent: 5252566 (1993-10-01), Shuman
patent: 5332726 (1994-07-01), Klein
patent: 5380713 (1995-01-01), Balasubramanian
patent: 5416093 (1995-05-01), Shuman
Bajusa et al. "Highly active and selective atcoagulants:D-phe-pro-arg-H, a free tripeptide adehyde . . . " J. Med. Che. v. 33, pp. 1729-1735 (1990).
Banner et al. "Serine proteases: 3D structure, mechanism of action and inhibitors" Persp. Med. Chem. Testa Bernard Ed. Verlag (pubsh.) pp. 29-43 (1993).
Balasubramanian, et al. J. Med. Chem. 1993, 36, No. 2 pp. 300-303.
Shuman et al. J. Med. Chem., 1993, 36, No. 3 pp. 314-319.
Kettner et al. The Journal of Biol. Chem., vol. 265, No. 30, Issue of Oct. 25; pp. 18289-18297 1990.
J. Biol. Chemistry, Platelet Glycocalicin vol. 263, No. 10, pp. 3435-3443, T. Okumura et al. (1978).
J. of Biol. Chem., The Binding of Thrombin to the Surface of Human Platelets, vol. 249, No. 8 pp. 2646-2651, 1974, Tollefsen et al.
Cell., Molecular Cloning of a Functional Thrombin . . . , vol. 64, pp. 1057-1068, Mar. 22, 1991.
J. of Biol. Chemistry, Thrombin Interaction with Platelets, vol. 262, No. 7 pp. 3030-3036 (1987), Gronke et al.
J. of Biol. Chem., Structure-Function Relations in the Interaction of alpha-Thrombin wth Blood Platelets, vol. 252, No. 20, 7118-7123 (1977), Workman et al.
Biochemical & Biophysical Research Commun., Minimal Sequence Requirement of Thrombin Receptor Agonist Peptide, vol. 184, No. 2 pp. 790-796 (1992), Kwan Y. Hui et al.
J. of Biol. Chem., Communication, vol. 267, No. 19, Jul., pp. 13146-13149, Scarborough et al. (1992).
J. of Biol. Chem., "Structure-Function Relationships in the Activation of Platelet Thrombin Receptors by Receptor-derived Peptides", vol. 267, No. 9, pp. 6081-6085, 1992, Vassallo et al. (1992).
Organic & Medicinal Chemistry Letters, alpha-Hydroxy-and alpha-Ketoester Functionalized Thrombin Inhibitors, vol. 2, No. 12, pp. 1607-1612, Iwanowicz et al., (1992).
J. Am. Chem. Soc., Design, Synthesis and Kinetic Evaluation of a Unique Cladd of Elastase Inhibitors . . . , 114, 1854-1863, Edwards et al. (1992).
Thrombos, Diathes, haemorrh. (Stuttg.), Thrombin Interaction with Human Platelets . . . 1974, 32, 207, David R. Phillips.
Chapter 3, Dept. of Biochemistry, St. Jude Children's Research Hospital, Platelet membrane proteins:composition and receptor function, Berndt and Phillips (1981).
Biochemistry, Platelet Stimulation by Thrombin and Other Proteases, vol. 14, No. 6, 1975, Martin et al.
Blood, PPack-Thrombin Inhibits Thrombin-Induced Platelet Aggregation . . . vol.75, No. 10 1990, pp. 1983-1990, Greco et al.
The Embo Journal, The refined 1.9 A crystal structure of human alpha-thrombin . . . , vol. 8, No. 11 pp. 3467-3475, Bode et al. (1989).
Elsevier Science Publishers Ltd. vol. 14, Oct. 1993, Tappanelli et al.
Piptides, vol. 12, pp. 1153-1154, Anticoagulant Activity of a Peptide Boronic Hussain et al. (1991).
Brady Stephen F.
Lumma William C.
Tucker Thomas J.
Vacca Joseph P.
Chang Ceila
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385612